Lorraine Harper

Publications

  1. 2021
  2. E-pub ahead of print
  3. 2020
  4. Accepted/In press
  5. Accepted/In press
  6. Accepted/In press

    Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

    Lorraine Harper, Apr 2020, (Accepted/In press) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journalArticlepeer-review

  7. Published

    Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis

    Lorraine Harper, Samir Mehta & Natalie Rowland, 13 Feb 2020, In: The New England Journal of Medicine. 382, 7, p. 622-631 10 p.

    Research output: Contribution to journalArticlepeer-review

  8. 2019
  9. Published
  10. Published
  11. Published
  12. 2018
  13. Published
  14. Published
  15. Published
  16. E-pub ahead of print
  17. Published
  18. Published
  19. 2017
  20. Published

    Avoidance of Harm From Treatment for ANCA-Associated Vasculitis

    Lorraine Harper, Dec 2017, In: Current Treatment Options in Rheumatology. 3, 4, p. 230-243 14 p.

    Research output: Contribution to journalReview articlepeer-review

  21. Published

    The European Vasculitis Society 2016 Meeting Report

    Lorraine Harper, Mark Little, Nov 2017, In: Kidney International Reports. 2, 6, p. 1018-1031

    Research output: Contribution to journalArticlepeer-review

  22. Published

    Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis

    Lorraine Harper, Sep 2017, In: Journal of the American Society of Nephrology. 28, 9, p. 2756-2767 12 p.

    Research output: Contribution to journalArticlepeer-review

  23. Published
  24. Published
  25. 2016
  26. Published
Previous 1 2 3 4 5 6 7 Next